Information
-
Trademark
-
98291104
-
International Classifications
-
Filing Date
November 29, 2023
11 months ago
-
Transaction Date
August 13, 2024
2 months ago
-
Status Date
August 13, 2024
2 months ago
-
Published for Opposition Date
June 18, 2024
4 months ago
-
Location Date
August 13, 2024
2 months ago
-
Status Code
688
-
Current Location
INTENT TO USE SECTION
Employee Name
CASTRO, GIANCARLO
-
Attorney Docket Number
189898.00055
Attorney Name
Christopher D. Olszyk, Jr.
Law Office Assigned Location Code
M10
-
Owners
Mark Drawing Code
3
Mark Identification
ONCOTIME
Case File Statements
- DM0000: The mark consists of the wording "Onco" in blue followed by "TIME" in orange and wherein the inner circle of the first letter "O" contains a series of orange balls being five larger balls and 12 smaller balls randomly placed; the color white is not part of the mark but represents background or shading.
- GS0051: Research use only chemical reagents for clinical medical or veterinary purposes; diagnostic reagents for medicinal research use
- PM0001: ONCO TIME
- CC0000: The color(s) blue and orange is/are claimed as a feature of the mark.
- GS0011: Diagnostic reagents, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
- GS0101: Research use only biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; Research use only cancer screening tests and devices, namely, medical devices for evaluating immunotherapy cancer treatment options; Research use only cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; Research use only medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patient
- GS0421: Providing reagent sample testing and diagnostic services for others in the field of cancer testing research, tumor testing research, and screening for the purpose of evaluating patient immunotherapy cancer treatment options
Case File Event Statements
-
11/29/2023 - 11 months ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
2/28/2024 - 8 months ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSM
-
3/29/2024 - 7 months ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
4/1/2024 - 7 months ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
2/28/2024 - 8 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
4/1/2024 - 7 months ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/1/2024 - 7 months ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
5/9/2024 - 6 months ago
11 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/8/2024 - 6 months ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
5/8/2024 - 6 months ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
5/9/2024 - 6 months ago
10 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
5/29/2024 - 5 months ago
12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
6/18/2024 - 4 months ago
13 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
6/18/2024 - 4 months ago
14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
8/13/2024 - 2 months ago
15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM